fig2
![The role of melatonin as an adjuvant therapeutic strategy in the modulation of carcinogenesis. A narrative review](https://image.oaes.cc/978d406c-3dfc-4b4b-9e48-677f068fe2e4/jcmt4005.fig.2.jpg)
Figure 2. Melatonin-specific cellular receptors. AhR: Aryl hydrocarbon receptor; MT: melatonin receptor; QR2: quinine reductase.
Figure 2. Melatonin-specific cellular receptors. AhR: Aryl hydrocarbon receptor; MT: melatonin receptor; QR2: quinine reductase.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/